Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 7 on this page, newest registry updates first. Search checked 2026-11-08 18:48 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 4UnknownINTERVENTIONAL

Desmopressin for Bleeding Related to Low Body Temperature

ClinicalTrials.gov · NCT00902057 · Registry updated: 2009-05-14

Condition / research focus: Hypothermia Induced Impairment of Primary Haemostasis
Sponsor: The University of Hong Kong
Countries with listed sites: China
Registry dates and results: Start: 2009-06. Completion: 2011-06 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin (drug)
desmopressin (drug)
desmopressin (drug)
placebo (drug)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The University of Hong Kong
Hong Kong, Hong Kong, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders

ClinicalTrials.gov · NCT00632242 · Registry updated: 2009-01-09

Condition / research focus: Purpura, Thrombotic Thrombocytopenic; Von Willebrand Disease Type-2b
Sponsor: Archemix Corp.
Countries with listed sites: Austria
Registry dates and results: Start: 2008-01. Completion: 2008-12 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ARC1779 (drug)
ARC1779 (drug)
ARC1779 (drug)
ARC1779 (drug)
ARC1779 (drug)

Where the study takes place — 1 listed sites

Archemix Investigational Site
Vienna, Austria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction

ClinicalTrials.gov · NCT00816127 · Registry updated: 2009-01-01

Condition / research focus: Liver Cirrhosis; Coagulopathy
Sponsor: Icahn School of Medicine at Mount Sinai
Countries with listed sites: United States
Registry dates and results: Start: 2003-10. Completion: 2007-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)
blood transfusion (biological)

Where the study takes place — 1 listed sites

Mount Sinai School of Medicine
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3TerminatedINTERVENTIONAL

Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis

ClinicalTrials.gov · NCT00592566 · Registry updated: 2008-01-14

Condition / research focus: Leptospirosis
Sponsor: Mahidol University
Countries with listed sites: Thailand
Registry dates and results: Start: 2003-07. Completion: 2006-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dexamethasone, desmopressin (drug) — also listed as: Minirin

Where the study takes place — 1 listed sites

Loei Hospital
Mueng, Changwat Loei, Thailand
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Treatment and Management of Women With Bleeding Disorders

ClinicalTrials.gov · NCT00111215 · Registry updated: 2007-03-13

Condition / research focus: Menorrhagia; Blood Coagulation Disorders; Blood Platelet Disorders; Von Willebrand Disease; Hematologic Disease
Sponsor: Centers for Disease Control and Prevention
Countries with listed sites: United States
Registry dates and results: Start: 2001-01. Completion: 2006-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tranexamic Acid (drug)
Desmopressin Acetate (drug)

Where the study takes place — 6 listed sites

Emory University School of Medicine
Atlanta, Georgia, United States
Site recruitment: Not reported
Michigan State University
East Lansing, Michigan, United States
Site recruitment: Not reported
The Mayo Clinic
Rochester, Minnesota, United States
Site recruitment: Not reported
UMDNJ Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
Site recruitment: Not reported
Mary M. Gooley Hemophilia Center
Rochester, New York, United States
Site recruitment: Not reported
Duke University Medical Center
Durham, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Study of Novel Types of Familial Diabetes Insipidus

ClinicalTrials.gov · NCT00004364 · Registry updated: 2006-02-22

Condition / research focus: Diabetes Insipidus
Sponsor: National Center for Research Resources (NCRR)
Countries with listed sites: No country reported
Registry dates and results: Start: 1995-12. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus

ClinicalTrials.gov · NCT00004363 · Registry updated: 2005-06-24

Condition / research focus: Diabetes Insipidus; Diabetes Insipidus, Neurohypophyseal
Sponsor: National Center for Research Resources (NCRR)
Countries with listed sites: United States
Registry dates and results: Start: 1995-12. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

chlorpropamide (drug)
desmopressin (drug)

Where the study takes place — 1 listed sites

Northwestern University Medical School
Chicago, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 7 on this page, newest registry updates first. Search checked 2026-11-08 18:48 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 4UnknownINTERVENTIONAL

Desmopressin for Bleeding Related to Low Body Temperature

ClinicalTrials.gov · NCT00902057 · Registry updated: 2009-05-14

Condition / research focus: Hypothermia Induced Impairment of Primary Haemostasis
Sponsor: The University of Hong Kong
Countries with listed sites: China
Registry dates and results: Start: 2009-06. Completion: 2011-06 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin (drug)
desmopressin (drug)
desmopressin (drug)
placebo (drug)

Where the study takes place — 1 listed sites

The University of Hong Kong
Hong Kong, Hong Kong, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders

ClinicalTrials.gov · NCT00632242 · Registry updated: 2009-01-09

Condition / research focus: Purpura, Thrombotic Thrombocytopenic; Von Willebrand Disease Type-2b
Sponsor: Archemix Corp.
Countries with listed sites: Austria
Registry dates and results: Start: 2008-01. Completion: 2008-12 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ARC1779 (drug)
ARC1779 (drug)
ARC1779 (drug)
ARC1779 (drug)
ARC1779 (drug)

Where the study takes place — 1 listed sites

Archemix Investigational Site
Vienna, Austria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction

ClinicalTrials.gov · NCT00816127 · Registry updated: 2009-01-01

Condition / research focus: Liver Cirrhosis; Coagulopathy
Sponsor: Icahn School of Medicine at Mount Sinai
Countries with listed sites: United States
Registry dates and results: Start: 2003-10. Completion: 2007-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)
blood transfusion (biological)

Where the study takes place — 1 listed sites

Mount Sinai School of Medicine
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3TerminatedINTERVENTIONAL

Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis

ClinicalTrials.gov · NCT00592566 · Registry updated: 2008-01-14

Condition / research focus: Leptospirosis
Sponsor: Mahidol University
Countries with listed sites: Thailand
Registry dates and results: Start: 2003-07. Completion: 2006-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dexamethasone, desmopressin (drug) — also listed as: Minirin

Where the study takes place — 1 listed sites

Loei Hospital
Mueng, Changwat Loei, Thailand
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Treatment and Management of Women With Bleeding Disorders

ClinicalTrials.gov · NCT00111215 · Registry updated: 2007-03-13

Condition / research focus: Menorrhagia; Blood Coagulation Disorders; Blood Platelet Disorders; Von Willebrand Disease; Hematologic Disease
Sponsor: Centers for Disease Control and Prevention
Countries with listed sites: United States
Registry dates and results: Start: 2001-01. Completion: 2006-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tranexamic Acid (drug)
Desmopressin Acetate (drug)

Where the study takes place — 6 listed sites

Emory University School of Medicine
Atlanta, Georgia, United States
Site recruitment: Not reported
Michigan State University
East Lansing, Michigan, United States
Site recruitment: Not reported
The Mayo Clinic
Rochester, Minnesota, United States
Site recruitment: Not reported
UMDNJ Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
Site recruitment: Not reported
Mary M. Gooley Hemophilia Center
Rochester, New York, United States
Site recruitment: Not reported
Duke University Medical Center
Durham, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Study of Novel Types of Familial Diabetes Insipidus

ClinicalTrials.gov · NCT00004364 · Registry updated: 2006-02-22

Condition / research focus: Diabetes Insipidus
Sponsor: National Center for Research Resources (NCRR)
Countries with listed sites: No country reported
Registry dates and results: Start: 1995-12. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus

ClinicalTrials.gov · NCT00004363 · Registry updated: 2005-06-24

Condition / research focus: Diabetes Insipidus; Diabetes Insipidus, Neurohypophyseal
Sponsor: National Center for Research Resources (NCRR)
Countries with listed sites: United States
Registry dates and results: Start: 1995-12. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

chlorpropamide (drug)
desmopressin (drug)

Where the study takes place — 1 listed sites

Northwestern University Medical School
Chicago, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →